Abstract 3217: Prasugrel 60/10 mg Compared with Clopidogrel 600/75 mg Results in Fewer Poor Responders Using Definitions of Platelet Reactivity Associated with Clinical Outcomes
David Erlinge(Lund University), Lars Wallentin(Uppsala University), Stefan James(Uppsala University), Kenneth J. Winters(Eli Lilly (United States)), Christoph Varenhorst, John T. Brandt(Universitätsklinikum Würzburg), Joseph A. Jakubowski(Indiana Biosciences Research Institute), Oscar Ö. Braun(Lund University), Tim Costigan, Agneta Siegbahn(Uppsala University)
Circulation
October 31, 2007
Cited by 0
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k